ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005

NCI Establishes New Program Project Grant Guidelines.

January 13, 2006

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

Three Community Based Programs Slated for Early Phaseout, Others Modified, Provided NCAB Agrees

February 29, 1980

GAO Study Finds Lumpectomy Effective As Mastectomy In Trials And In Practice

November 25, 1994